Eli Lilly & Co. (LLY) Tops Q1 EPS by 21c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Eli Lilly (LLY) PT Raised to $82 at Credit Suisse
April 25, 2018 8:59 AM EDTCredit Suisse raised its price target on Eli Lilly (NYSE: LLY) to $82.00 (from $80.00) while maintaining a Underperform rating.
... MoreEli Lilly (LLY) PT Lowered to $78 at BMO Capital
April 25, 2018 7:13 AM EDTBMO Capital lowered its price target on Eli Lilly (NYSE: LLY) to $78.00 (from $79.00) while maintaining a Market Perform rating.
Analyst Alex Arfaei commented, "The revenue and EPS beat in 1Q18 looked impressive, but since it was driven by the mature... More
Eli Lilly (LLY) PT Maintained at $95 at Cowen on 1Q18 Report; 'Top & Bottom Line Beat... FY18 Guidance Raised'
April 24, 2018 11:50 AM EDTCowen maintained its price target on Eli Lilly (NYSE: LLY) at $95.00 while maintaining a Outperform rating, following the company's first quarter earnings report.
Analyst Steve Scala notes an upbeat outlook on the shares, as LLY reported first quarter sales and earnings per share results above... More
